[The use of human gamma globulin in antibiotic resistant pyogenic cases].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002056:Burns / Q000628:therapy; D002181:Candidiasis, Vulvovaginal / Q000628:therapy; D002481:Cellulitis / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D002763:Cholecystectomy; D004352:Drug Resistance, Microbial; D004761:Enterocolitis, Pseudomembranous / Q000628:therapy; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007239:Infections / Q000276:immunology / Q000628:therapy*; D052177:Kidney Diseases, Cystic / Q000628:therapy; D007871:Leg Ulcer / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000628:therapy; D010309:Parotitis / Q000628:therapy; D010538:Peritonitis / Q000628:therapy; D010587:Phagocytosis; D011014:Pneumonia / Q000628:therapy; D011183:Postoperative Complications / Q000628:therapy; D011702:Pyelitis / Q000628:therapy; D013203:Staphylococcal Infections / Q000628:therapy; D005719:gamma-Globulins / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D005719:gamma-Globulins
Die Anwendung von Humangammaglobulin bei antibiotikaresistenten pyogenen Fällen.